Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Clarivate $75M Debt Financing with Clarivate Science Holdings Corporation
Clarivate Plc announced the final results of a cash tender offer to repurchase up to $75 million of its 3.875% Senior Secured Notes due 2028. Although $665.2 million in principal was tendered by holders, the company accepted only the maximum amount of $75 million, resulting in a proration factor of 11.3%.
Greenland Energy Company entered into a Deed of Variation and Novation with 80 Mile plc to amend and extend their existing joint venture farm-out agreement for oil exploration in Greenland's Jameson Land Basin. The agreement extends the drilling deadlines for two exploration wells to December 31, 2028, and transfers direct permitting responsibility to Greenland Energy in exchange for a £500,000 cash payment.
Archer Aviation announced the expiration of the Hart-Scott-Rodino (HSR) Act waiting period regarding its acquisition of Boeing subsidiaries Wisk Aero, SkyGrid, and Insitu. This satisfies a key closing condition for the transaction, which aims to create an end-to-end physical AI platform for aerospace and defense. The deal is currently expected to close by the end of 2026, subject to remaining regulatory approvals.
Forefront Tech Holdings Acquisition Capital Raise of $100M
Forefront Tech Holdings Acquisition Corp filed an amendment to correct its IPO closing details, confirming that $100.3 million was deposited into its trust account. The filing also details the private placement of 370,000 units to its Sponsor and underwriter BTIG, LLC, generating $3.7 million in additional gross proceeds. The company has 18 months from the IPO closing to complete its initial business combination.
Independence Realty Trust, Inc. (IRT) filed a formal investor presentation as an exhibit to its 8-K. The filing was made under Item 7.01 (Regulation FD Disclosure) to provide updated strategic and operational information to the investment community.
Aptevo Therapeutics announced operational progress in its next-generation trispecific cancer programs, specifically focusing on optimizing manufacturing scalability for its lead candidate, APVO451. The company expects to initiate Investigational New Drug (IND) enabling studies for APVO451 in the first half of 2027. This update signals the transition of the trispecific platform from molecular design toward clinical development readiness.
TPG Private Equity Opportunities, L.P. reported the unregistered sale of equity securities under Item 3.02. As a private equity fund structure, this typically represents the issuance of partnership interests or shares to investors in connection with capital commitments or a continuous offering.
Newton Golf Company M&A Deal with Cannon Bridge Mining Services
Newton Golf Company entered into an assignment agreement to acquire an exclusive option for a 100% ownership interest in the Pole Canyon Project, a 330-acre mining site in Nevada. The company assumed $200,000 in cash obligations and $200,000 in share consideration, while issuing 19.9% of its outstanding common stock to designees of Spartan Crest Capital Corp. in exchange for the assignment.
Charles River Laboratories International Investor Presentation
Charles River Laboratories is hosting its 2026 Investor Day to unveil its 'Pathway to Purpose' strategic vision, which aims to modernize operations and generate over $300 million in cumulative savings through 2030. The company reaffirmed its 2026 guidance at the upper end of prior ranges and introduced long-term targets including a 5-7% organic revenue CAGR and a ~24% non-GAAP operating margin by 2030.
H.B. Fuller reported third-quarter 2026 net revenue of $938 million, a 5.2% increase year-over-year, driven by pricing execution that offset lower volumes. Adjusted EBITDA rose 9% to $187 million with a record margin of 19.9%, while adjusted EPS grew 21% to $1.52. The company noted that pricing actions and restructuring savings are successfully offsetting higher raw material costs.
Term
Q3 2026
Earnings call
Sep 24, 2026, 10:30 AM ET
“Through disciplined execution, we delivered strong revenue, EBITDA, and EPS growth in the quarter and continued to improve profitability and advance toward our EBITDA margin target of greater than 20 percent.”
Celeste Mastin, president and chief executive officer
“Pricing actions are offsetting higher raw material costs, and our restructuring efforts continue to enhance operating leverage. With the anticipated closing of the AMS acquisition before year-end, we remain focused on strengthening our portfolio, executing our Quantum Leap program, and creating long-term value for shareholders.”
Celeste Mastin, president and chief executive officer
Sky Quarry Inc. has received an air permit from the Nevada Division of Environmental Protection and restarted operations at its Eagle Springs Refinery near Ely, Nevada. The company completed $300,000 in repairs and upgrades to the facility, which has a nameplate capacity of 5,000 barrels of crude oil per day. The restart allows the company to begin ramping up production of Nevada-refined products to serve the regional market.
HCW Biologics entered into a securities purchase agreement with an institutional investor to raise approximately $1.5 million through the sale of 903,614 units. Each unit consists of a pre-funded warrant and a common stock purchase warrant, with proceeds intended for working capital and clinical development activities.
Fifth Third Bancorp $500M Debt Financing with Wilmington Trust Company
Fifth Third Bancorp has issued a redemption notice for all $500 million of its outstanding 1.707% Fixed Rate/Floating Rate Senior Notes due 2027. The notes will be redeemed on November 1, 2026, at 100% of the principal amount plus accrued interest, one year ahead of their scheduled maturity date.
Partners Group Lending Fund $75M Debt Financing with Sumitomo Mitsui Banking Corporation
Partners Group Lending Fund, LLC's subsidiary, PG BDC Finance II, LLC, entered into a $75 million secured credit facility with Sumitomo Mitsui Banking Corporation (SMBC) as administrative agent. The facility includes an uncommitted accordion feature allowing for a total potential capacity of up to $1 billion to finance the acquisition and origination of eligible loan assets. The facility has a 36-month reinvestment period and is benchmarked to Term SOFR for U.S. dollar draws.
Commvault Systems appointed David Morton, Jr. to its Board of Directors and as Chairperson of the Operating Committee, effective September 22, 2026. Mr. Morton currently serves as CFO of Intapp and brings extensive experience in SaaS and cybersecurity finance from previous roles at DigiCert, Anaplan, and Seagate Technology. He will receive compensation in accordance with the company's non-employee director policy, consisting of cash and restricted stock units.
Auddia Inc. has adjourned its special meeting of stockholders until October 7, 2026, to allow more time to solicit proxies for its proposed merger with Thramann Holdings, LLC. While approximately 88% of votes cast to date are in favor of the transaction, the company has not yet reached the required threshold of a majority of all outstanding shares. The merger, if completed, would result in the formation of a new AI-native operating company called McCarthy Finney, Inc.
Columbus Acquisition Corp is providing updated time and location details for its reconvened Extraordinary General Meeting of Shareholders, now scheduled for September 28, 2026. The meeting will be held both in-person in New York and virtually via teleconference to address matters previously outlined in the company's definitive proxy statement.
Navi Grewal, Executive Vice President and Chief Digital and Technology Officer of MasterBrand, Inc., notified the company of her resignation effective October 15, 2026. She is leaving to pursue another opportunity, and the company stated her departure is not due to any disagreements regarding operations, policies, or practices.
Michael Akkerman, the Chief Business Officer of Digital Turbine, Inc., resigned from his position on September 23, 2026. His departure is effective October 30, 2026, as he has accepted a Chief Executive Officer role at another company.
Kim Balle, CFO, sold 42,533 shares of Torm plc at $36.35 to $39.16 a share (average $38.63) in 3 transactions, worth $1.64M in total between Sep 18, 2026 and Sep 22, 2026. Shares held after the trade: 510 (-93.7%).
Mexico Fund Insider Saba Capital Management L.P. Buys $598K of Stock
Saba Capital Management L.P. bought 28,464 shares of Mexico Fund Inc at $21.02 a share, worth $598K in total on Sep 23, 2026. Shares held after the trade: 2,341,186 (+1.2%).
aTyr Pharma reached alignment with the FDA on the protocol for a new Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease. The global study is expected to enroll approximately 372 patients and initiate study-related activities in the fourth quarter of 2026.
Newton Golf Company entered into warrant exchange agreements with three holders to repurchase Series A Common Warrants previously exercisable for 749,999 shares. In exchange, the company issued 232,202 shares of common stock and granted the holders a 12-month right of first refusal to participate in 10% of future equity offerings.
Elmet Group Signs $125M M&A Deal with Masan High-Tech Materials Corporation
The Elmet Group Co. entered into a definitive agreement to acquire a 4.99% equity stake in Vietnam-based Masan High-Tech Materials Corporation for approximately $124.75 million. The transaction formalizes a 12-year commercial relationship and includes long-term supply agreements for mined tungsten and conversion services to secure Elmet's supply chain. The deal follows a recent $450 million investment commitment from the U.S. Government to Elmet for critical materials infrastructure.
Nuveen Credit Strategies Income Fund Leadership Change
Himani Trivedi will retire from Nuveen on June 30, 2027, and will step down as portfolio manager of the Nuveen Credit Strategies Income Fund effective October 31, 2026. Scott Caraher, James Kim, and Coale Mechlin will continue to manage the Fund, and no changes to investment objectives or policies are expected.
Vistagen presented positive exploratory data at Psych Congress 2026 showing that its Phase 3 candidate fasedienol (PH94B) demonstrated statistically significant improvements in anxiety symptoms for patients with very severe social anxiety disorder. The findings, derived from post-hoc and prespecified subpopulation analyses of the PALISADE-4 and Phase 2a RDS trials, suggest that fasedienol may provide rapid-onset relief and that a second dose could further improve anticipatory anxiety.
Wabash National Corporation has filed a formal investor presentation dated September 24, 2026, to be used for upcoming investor conferences. The presentation is furnished under Item 7.01 and provides strategic and operational updates to the investment community.
BlackBerry reported Q2 fiscal 2027 revenue of $163 million, a 26% year-over-year increase, driven by record performance in its QNX segment. The company achieved its second consecutive 'Rule of 40' performance with adjusted EBITDA growing 81% to $47 million and generated $29 million in operating cash flow. Based on strong first-half execution, BlackBerry raised its full-year fiscal 2027 revenue and adjusted EBITDA outlook.
Term
Q2 2027
“Our strong second quarter performance provides further evidence that BlackBerry’s profitable growth model is working, with revenue, profitability, and cash flow generation all exceeding our expectations.”
John J. Giamatteo, CEO, BlackBerry
“QNX delivered record performance in the quarter, driven by strength in our core automotive business. The first Alloy Kore design win, the largest design win in QNX history, marks an important commercial milestone.”
TD SYNNEX reported record fiscal third quarter results with revenue of $21.6 billion, up 37.7% year-over-year, and GAAP diluted EPS of $5.18. The company also increased its quarterly dividend by 9% to $0.48 per share and provided Q4 revenue guidance of $21.8 to $22.6 billion.
Term
Q3 2026
Earnings call
Oct 16, 2026, 9:00 AM ET
“We delivered another record quarter, with Distribution and Hyve both performing above our expectations and growing above market.”
Patrick Zammit, CEO of TD SYNNEX
“Enterprise AI adoption is progressing toward broader production deployments. Data center modernization remains a priority as organizations prepare for next-generation infrastructure requirements, while AI is driving new security, governance, and compliance requirements across technology environments.”
Cullinan Therapeutics outlined its anticipated pipeline milestones for the fourth quarter of 2026, including data readouts for its T cell engager programs CLN-978, velinotamig, and CLN-049. The company plans to share multi-dose regimen data for CLN-978 across SLE, RA, and Sjögren’s disease in December, and velinotamig data at the ACR Convergence conference in November.